Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability

ConclusionIn a subset of postmenopausal women at increased risk of fracture as judged by CHMP guidance, abaloparatide significantly decreased the risk of all fracture endpoints compared with placebo.

http://link.springer.com/10.1007/s11657-019-0564-7

Source: Archives of Orthopaedic and Trauma Surgery - February 5, 2019 Category: Orthopaedics Source Type: research